A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

24, 2025 (HealthDay News) -- People can reverse their type 2 diabetes through a combination of calorie cutting and medication ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk reported turnover from obesity treatments soared by 57 per cent to 65.1 billion Danish kroner last year, largely ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...